Publications for Emelie Djerf

Publications for Emelie DjerfCo-author map based on ISI articles 2007-

Journal Articles

Emelie Djerf, Cecilia Trinks, Henrik Green, Avni Abdiu, Anna-Lotta Hallbeck, Olle Stål and Thomas Walz
  The pan-ErbB receptor tyrosine kinase inhibitor canertinib promotes apoptosis of malignant melanoma in vitro and displays anti-tumor activity in vivo
  Biochemical and Biophysical Research Communications - BBRC, 2011, 414(3), 563-568.
 Web of Science® Times Cited: 2

Cecilia Trinks, Emelie A. Severinsson, Birgitta Holmlund, Anna Gréen, Henrik Green, Jan-Ingvar Jönsson, Anna-Lotta Hallbeck and Thomas Walz
  The pan-ErbB tyrosine kinase inhibitor canertinib induces caspase-mediated cell death in human T-cell leukemia (Jurkat) cells
  Biochemical and Biophysical Research Communications - BBRC, 2011, 410(3), 422-427.
 Web of Science® Times Cited: 1

Cecilia Trinks, Emelie Djerf, Anna-Lotta Hallbeck, Jan-Ingvar Jönsson and Thomas Walz
  The pan-ErbB receptor tyrosine kinase inhibitor canertinib induces ErbB-independent apoptosis in human leukemia (HL-60 and U-937) cells
  BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2010, 393(1), 6-10.
 Web of Science® Times Cited: 6

Emelie Djerf, Cecilia Trinks, Avni Abdiu, Lena Thunell, Anna-Lotta Hallbeck and Thomas M Walz
  ErbB receptor tyrosine kinases contribute to proliferation of malignant melanoma cells: inhibition by gefitinib (ZD1839)
  Melanoma research, 2009, 19(3), 156-166.
 Web of Science® Times Cited: 21

Ph.D. Theses

Emelie Severinsson
  Experimental studies on ErbB targeted therapy in malignant melanoma
  2012.


  Fulltext PDF

Licentiate Theses

Emelie Djerf
  Studies on the effect of ErbB tyrosine kinase inhibitors on malignant melanoma growth and survival in vitro
  2009.


  Fulltext PDF